Strategic Integration DORC recently integrated with ZEISS Group, expanding access to its Eva Nexus VR surgery platform through a larger medical technology ecosystem. This signals a collaborative sales opportunity to cross-sell complementary imaging and surgical platforms within ZEISS' customer base.

Product Expansion Ongoing and past launches such as EVA NEXUS and TissueBlue indicate a strong pipeline of advanced surgical tools and visualization aids. This creates opportunities to upsell to clinics adopting new retina and cataract solutions and to expand footprint across ophthalmic centers.

Regulatory Leverage Regulatory approvals in multiple regions (FDA for TissueBlue, Health Canada approval) demonstrate a credible path to international sales and can ease expansion into new markets through compliance-driven selling points.

Global Partnerships Existing distribution partnerships (e.g., Vision Med Hellas) and international presence suggest prioritizing regional channel strategies and co-marketing with distributors to accelerate penetration in targeted markets.

Financial Readiness With substantial funding and a revenue range indicative of scalable operations, there is capacity for customers to adopt bundled equipment packages and service contracts, enabling value-based selling and longer-term procurement deals.